Published in Cancer Weekly, April 14th, 2009
"A more efficient approach to induce HLA-A2 restricted CTLs, through immunization with a multi-epitope DNA vaccine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-04-14)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.